Sexually transmitted infection (STI) clinics are used by large numbers of individuals at substantial risk of HIV, and their focus on sexual health makes PrEP easy to integrate in the provider-patient discussion. HIV testing, risk assessments, and discussions about HIV prevention are already happening...
Pre-exposure prophylaxis—or PrEP for short—is the term for the use of HIV medications to prevent an HIV infection before it occurs. It has been a strategy approved in the United States since 2012, when the U.S. Food and Drug Administration approved the pill Truvada for use as PrEP. Si...
injection drug useHIV preventionLimited research has examined pre-exposure prophylaxis (PrEP) interest among people who inject drugs (PWID). To date, few studies have examined the relationship between PrEP eligibility and PrEP interest among PWID. Data were from an anonymous, cross-sectional survey ...
Participants also generally prefer newer injectable pre-exposure prophylaxis compared to pills for HIV prevention. Read More Clinical Overview: Apretude for HIV Pre-Exposure Prophylaxis Dan Paul, PharmD, MPBA February 2nd 2023 Apretude is an antiretroviral drug that inhibits HIV replication by binding...
safety, and sexual pleasure is imperative for Black women’s sexual well-being. [3,4] While sexual well-being is not defined by the absence of a health condition, modern tools for the prevention of HIV present key opportunities, though unreached, to support the sexual well-being of Black ...
Eligibility criteria: (1) male sex at birth; (2) aged ≥ 18 years; (3) sexually active with other men in the past year; and (4) HIV-negative or unknown. This study was approved by the Institutional Review Boards of Chinese Center for Disease Control and Prevention (Approval Notice No....
Overall, for evaluating PrEP success, numbers of HIV infections averted will need to be modelled based on a range of composite programmatic measures. One impor- tant metric will be uptake among those eligible for PrEP. However, eligibility will have to be well-defined and is currently different...
HIV risk perception is an important cognition for prevention, theoretically engendering service-seeking and risk-reduction behaviors, but its composition remains poorly understood. We examined country-specific correlates of self-appraised HIV exposure ri
Although these results are promising and trials are still in process, approval of DPR-VR in developing countries would need to act as a supplement to existing HIV-prevention practices. The ring could be another expansion in our “PrEP toolbox” to fight the global rate of HIV infection. Oth...
Approved by the U.S. Food and Drug Administration (FDA) since 2012, PrEPis highly effective for preventing HIVwhen taken as directed and reduces the risk of HIV from sex by 99% and from injection drug use by 74%. A newstudyin the journalAIDS Education and Preventioninvestigated primary car...